These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2840520)

  • 21. [Evaluation of risk index according to Tiselius in patients with calcium urinary stones].
    Głuszek J; Raszeja-Wanic B; Boruczkowska A; Musialik D
    Pol Tyg Lek; 1989 Feb; 44(9):223-5. PubMed ID: 2813184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential pitfalls of the 2-hour calcium-to-creatinine ratio and urinary cyclic adenosine monophosphate excretion in the differential diagnosis of idiopathic hypercalciuria.
    Heller JE; Konnak JW; Lau YK
    J Urol; 1984 May; 131(5):911-3. PubMed ID: 6323773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxalate measurement in the picomol range by ion chromatography: values in fasting plasma and urine of controls and patients with idiopathic calcium urolithiasis.
    Schwille PO; Manoharan M; Rümenapf G; Wölfel G; Berens H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):87-96. PubMed ID: 2746168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary citrate excretion in normal persons and patients with idiopathic calcium urolithiasis.
    Hosking DH; Wilson JW; Liedtke RR; Smith LH; Wilson DM
    J Lab Clin Med; 1985 Dec; 106(6):682-9. PubMed ID: 4067380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
    Ala-Opas M; Elomaa I; Porkka L; Alfthan O
    Scand J Urol Nephrol; 1987; 21(4):311-4. PubMed ID: 2832935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystalluria determined by polarization microscopy. Technique and results in healthy control subjects and patients with idiopathic recurrent calcium urolithiasis classified in accordance with calciuria.
    Herrmann U; Schwille PO; Kuch P
    Urol Res; 1991; 19(3):151-8. PubMed ID: 1887522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis.
    Matsushita K; Tanikawa K
    Tokai J Exp Clin Med; 1987 Sep; 12(3):167-71. PubMed ID: 3454077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine calcium/citrate ratio in children with hypercalciuric stones.
    Srivastava T; Winston MJ; Auron A; Alon US
    Pediatr Res; 2009 Jul; 66(1):85-90. PubMed ID: 19287339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical studies in paraplegic renal stone patients. 2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate.
    Burr RG; Nuseibeh I; Abiaka CD
    Br J Urol; 1985 Jun; 57(3):275-8. PubMed ID: 2988686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of weight and glucose ingestion on urinary calcium and phosphate excretion: implications for calcium urolithiasis.
    Ulmann A; Aubert J; Bourdeau A; Cheynel C; Bader C
    J Clin Endocrinol Metab; 1982 May; 54(5):1063-8. PubMed ID: 7061697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic hypercalciuria of childhood: 4- to 11-year outcome.
    Alon US; Berenbom A
    Pediatr Nephrol; 2000 Sep; 14(10-11):1011-5. PubMed ID: 10975318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary volume in children with urolithiasis.
    Miller LA; Stapleton FB
    J Urol; 1989 Apr; 141(4):918-20. PubMed ID: 2926890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.